GHISLANDI, SIMONE
 Distribuzione geografica
Continente #
EU - Europa 4.517
NA - Nord America 3.640
AS - Asia 1.752
SA - Sud America 230
AF - Africa 66
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 10.226
Nazione #
US - Stati Uniti d'America 3.457
RU - Federazione Russa 1.023
IT - Italia 966
FI - Finlandia 614
GB - Regno Unito 579
CN - Cina 558
SG - Singapore 458
IE - Irlanda 449
UA - Ucraina 209
DE - Germania 186
VN - Vietnam 185
BR - Brasile 169
CA - Canada 140
SE - Svezia 102
TR - Turchia 98
FR - Francia 96
HK - Hong Kong 95
KR - Corea 64
IN - India 62
BG - Bulgaria 43
BD - Bangladesh 39
ZA - Sudafrica 39
ES - Italia 31
AT - Austria 30
NL - Olanda 28
BE - Belgio 26
CZ - Repubblica Ceca 25
ID - Indonesia 25
MX - Messico 22
PL - Polonia 22
IL - Israele 20
JP - Giappone 16
MY - Malesia 16
AR - Argentina 15
PE - Perù 14
AU - Australia 12
RS - Serbia 12
CH - Svizzera 11
IQ - Iraq 11
GR - Grecia 10
PK - Pakistan 10
TH - Thailandia 10
NO - Norvegia 9
PH - Filippine 9
CO - Colombia 8
DK - Danimarca 8
IR - Iran 8
LK - Sri Lanka 8
UZ - Uzbekistan 8
EC - Ecuador 7
LT - Lituania 7
MA - Marocco 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
RO - Romania 6
SA - Arabia Saudita 6
TW - Taiwan 6
VE - Venezuela 6
AL - Albania 5
CL - Cile 5
NP - Nepal 5
EU - Europa 4
JM - Giamaica 4
KG - Kirghizistan 4
LB - Libano 4
PA - Panama 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
KZ - Kazakistan 3
MT - Malta 3
MW - Malawi 3
RW - Ruanda 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
GT - Guatemala 2
HN - Honduras 2
JO - Giordania 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NI - Nicaragua 2
PY - Paraguay 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
CR - Costa Rica 1
ET - Etiopia 1
GE - Georgia 1
Totale 10.216
Città #
Helsinki 569
Ashburn 459
Dublin 448
Southend 373
San Jose 338
Chandler 323
Ann Arbor 246
Singapore 230
Milan 228
Moscow 198
Hefei 180
Jacksonville 170
Dallas 166
Beijing 119
Council Bluffs 116
Houston 107
Toronto 98
Hong Kong 91
Dearborn 79
New York 72
Los Angeles 68
Rome 65
Seoul 61
Wilmington 59
The Dalles 55
Dong Ket 52
Edison 50
Lauterbourg 44
Lawrence 44
Frankfurt am Main 42
Boston 40
Johannesburg 34
Redwood City 34
Izmir 33
Hanoi 32
Ho Chi Minh City 31
Boardman 29
Woodbridge 29
Modena 27
Mountain View 27
Fremont 25
Fairfield 24
Seattle 23
Orem 22
Redmond 22
Buffalo 20
Munich 20
Jakarta 19
Old Bridge 19
Vienna 19
Warsaw 18
Brooklyn 16
Brussels 16
São Paulo 16
Tel Aviv 16
Denver 15
Turin 15
Assago 14
Palombara Sabina 14
Stockholm 14
Atlanta 13
Lima 13
Tokyo 13
Burgas 12
Falls Church 12
London 12
Mexico City 12
Nanjing 12
Santa Clara 12
Chicago 11
Montreal 11
Chennai 10
Genoa 10
Kunming 10
Lappeenranta 10
Paris 10
Belgrade 9
Florence 9
Aberdeen 8
Amsterdam 8
Granada 8
North Walsham 8
Bath 7
Bologna 7
Nevşehir 7
Phoenix 7
San Francisco 7
Tashkent 7
Ankara 6
Asti 6
Athens 6
Bari 6
Bonndorf 6
Brescia 6
Gavirate 6
Nanchang 6
Palermo 6
Pisa 6
Turku 6
Ampang 5
Totale 6.179
Nome #
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 446
Smoking in Italy 2008-2009: a rise in prevalence related to the economic crisis? 407
La diffusione di competenze cliniche e gestionali per lo sviluppo dei servizi del SSN : lezioni apprese dai Piani di Rientro e nuove prospettive 349
COVID-19 lockdown impact on lifestyle habits of Italian adults 334
Diffusion of medical technology:The role of financing 276
Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data 267
Family income and material deprivation: do they matter for sleep quality and quantity in early life? Evidence from a longitudinal study 261
Adaptation to poverty in long-run panel data 260
The economic crisis and acute myocardial infarction: new evidence using hospital-level data 259
Effects of the economic crisis on smoking prevalence and number of smokers in the USA 252
Effects of Reference Pricing in Pharmaceutical Markets: A Review 249
Fair choices in universal health coverage in Thailand 248
Inequalities in the benefits of national health insurance on financial protection from out-of-pocket payments and access to health services: cross-sectional evidence from Ghana 240
A simple measure of human development: the human life indicator 237
Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy 237
Competition and the Reference Pricing Scheme for pharmaceuticals 225
Years of Good Life (YoGL): a wellbeing indicator designed to serve research on sustainability 225
A repeated cross-sectional analysis on the economic impact of SARS-CoV-2 pandemic at the hospital level in Italy 223
Investigating the geographic disparity in quality of care: the case of hospital readmission after acute myocardial infarction in Italy 223
Lo Stato Sociale: oltre la redistribuzione 222
Lifespan inequalities among the over 50 in Italy: Evidence from administrative data 221
How do italian pharmacoeconomists evaluate indirect costs? 220
How do italian pharmacoeconomists evaluate indirect costs? 216
The impact of generic reference pricing in Italy, a decade on 200
Competition and the Reference Pricing Scheme for pharmaceuticals 195
Transformation of cancer care during and after the COVID pandemic, a point of no return : the experience of Italy 195
Corona-regionalism? Differences in regional responses to COVID-19 in Italy 190
The impact of generic reference pricing in Italy, a decade on 188
A real world analysis of COVID-19 impact on hospitalizations in older adults with chronic conditions from an Italian region 179
The impact of Universal Health Coverage on health care consumption and risky behaviours: evidence from Thailand 177
The Coronavirus pandemic and inequality in Italy 175
Labour tax reforms and labour market outcomes in Europe 174
L'inclusione dei costi indiretti nelle valutazioni economiche: la situazione italiana. 174
Is EQ-5D a valid measure of HRQoL in patients with movement disorders? 169
Sleep dissatisfaction and insufficient sleep duration in the Italian population 168
La politica farmaceutica in Spagna 167
Variables affecting pricing of orphan drugs: the Italian case 167
Regional tenders on biosimilars in Italy: An empirical analysis of awarded prices 165
Should we really worry about "launch delays" in OECD countries? 163
Misurazione soggettiva dello stato di salute: peculiarità dell'approccio economico. 156
Off patent drugs in Italy: a short sighted view? 155
Maternal genetic risk for depression and child human capital 154
Roll-your-own cigarettes in Europe: use, weight and implications for fiscal policies 149
What do we really know about reference pricing for pharmaceuticals? 149
Italian Pharmaceutical Policy: Towards a Structural Change? 141
Response to COVID-19: was Italy (un)prepared? 141
The role of technology and social media use in sleep-onset difficulties among Italian adolescents: cross-sectional study 130
Reference pricing in Finnish pharmaceutical markets: pre-policy evaluation. 126
The impact of budget cuts on individual patient health: Causal evidence from hospital closures 59
ESG Performance, Debt Financing, and R&D Output: Evidence From the Healthcare Sector 53
Totale 10.356
Categoria #
all - tutte 37.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.396


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022819 40 103 39 15 42 34 47 89 135 100 79 96
2022/20231.372 99 93 52 121 80 87 31 68 592 27 54 68
2023/2024788 54 38 58 15 71 92 46 153 23 48 84 106
2024/2025957 31 17 74 21 82 49 53 64 328 89 89 60
2025/20264.063 240 339 129 248 342 149 450 439 1.108 469 121 29
2026/2027116 116 0 0 0 0 0 0 0 0 0 0 0
Totale 10.356